| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6002343 | Thrombosis Research | 2014 | 27 Pages |
Abstract
The inhibitory effects of prolonged exposure of bortezomib on platelet aggregation were demonstrated in relapsed/refractory MM patients, but antithrombotic activity of bortezomib should be clarified in further prospective studies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Joanna Rupa-Matysek, Lidia Gil, Ewelina WojtasiÅska, Adam Nowicki, Dominik Dytfeld, Maciej Kaźmierczak, MieczysÅaw Komarnicki,